Ukpeagvik Inupiat Corporation and Subsidiary

Anchorage, AK Finance & insuranceNAICS 525990

Self-funded health planPlan year 2025Renews January
3,448Participants+9% vs. prior year
$8.2MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#1 of 2Finance & insurance in AKBy participants

Overview

Ukpeagvik Inupiat Corporation and Subsidiary sponsors a self-funded health plan that covered 3,448 participants in plan year 2025, up 9% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
3,448 · prior year 3,164
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Ukpeagvik Inupiat Corporation Group Health and Welfare Benefit Plan, plan 501 (3,448 participants)
Stop-loss carrier
Reliastar Life Insurance Company
Broker compensation
$178K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityLong-term disabilityDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Life Insurance Company of North AmericaLife, Short-term disability, Long-term disability3,448$3.0M$107K
Reliastar Life Insurance CompanyStop-loss1,604$693K$43K
Four Ever Life Insurance CompanyMedical, Prescription drug, Dental, Vision3,448$345K—
Cigna Health and Life Insurance CompanyCritical Illness, Accident, Hospital3,448$335K$25K
Hartford Accident and Life Insurance CompanyMedical, Prescription drug131$62K$3K
Cigna Health and Life Insurance Company and AffiliatesEmployee Assistance Program308$2K—

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$8.2M/ year

Estimated prescription spend: 3,448 participants × $2,371 national average per member. Usually higher once dependents are counted.

$213K–$524K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$62K–$155K
Lower-cost therapeutic alternatives$91K–$190K
Generic pricing vs. actual cost$39K–$118K
PBM contract terms$20K–$61K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Ukpeagvik Inupiat Corporation and Subsidiary
Sponsor EIN
92-0044212
Plan number
501
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 92-0044212 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Ukpeagvik Inupiat Corporation Employees' Retirement Plan
Type
401(k) plan
Participants
4,832

About this data

Source: Ukpeagvik Inupiat Corporation and Subsidiary's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Ukpeagvik Inupiat Corporation and Subsidiary.

Request a correction · Methodology